IHMRI CEO and Executive Director, Professor David J. Adams, has been appointed to the Advisory Committee of the NSW Government’s Cardiovascular Disease Research Capacity Development Program
The NSW Government has announced it will boost funding to fight heart disease by $150 million over the next ten years.
Sixty million dollars of that will be rolled out to researchers across the state over the next four years according to Premier Gladys Berejiklian.
“Heart disease remains Australia’s number one killer but with great investment, researchers can predict, prevent and treat it more accurately,” Mrs Berejiklian said. “If we want to keep people healthy, and reduce pressure on our clinical services, we have to curb the growing epidemic of cardiovascular disease.”
With a focus on biomedical research and innovation, the State Government’s Program is expected to significantly boost employment opportunities in science and technology, attracting the best and brightest researchers and clinicians to NSW.
The initiative will also support research grants aimed at advancing fundamental discoveries, to rapidly convert breakthroughs into better treatments for patients with heart disease.
Professor David J. Adams has welcomed the record investment for cardiovascular research.
“The NSW Government has shown great vision and foresight in making this commitment, guaranteeing the next generation of research excellence and first-class care for the community,” said Professor Adams.
“This will speed up the time that ground-breaking discoveries can be developed into better treatments for patients with heart disease.”
In his role on the Advisory Committee, Professor Adams will assist with criteria and processes for the funding rounds and provide strategic advice as required.
Top picture: IHMRI Clinical Director and Deputy Executive Director, Professor Leonard Arnolda; Professor Ben Freedman from the Heart Research Institute; the Hon. Brad Hazzard, NSW Minister for Health and Minister for Medical Research; and Professor Shaun Jackson from the Heart Research Institute, at the announcement of the new funding for cardiovascular disease on 3 June 2018.